The International Union Against Tuberculosis and Lung Disease (The Union) presented awards for scientific achievement and public health excellence to an eminent South African researcher and an innovative multidrug-resistant TB project launched in Siberia . Dr Kogieleum Naidoo received the annual Union Scientific prize for her published research on TB-HIV, and the Tomsk Oblast Tuberculosis and Pulmonology Medical Center in Russia received the Karel Styblo Public Health Prize for piloting the use of DOTS-Plus -Directly Observed Treatment, Short Course, for multidrug resistant TB (MDR-TB) – to combat MDR-TB. The Union presents these awards annually at the inaugural session of the Union World Conference on Lung Health, which is being held this year at the Palais des Congrès in Paris. The awards include a cash prize and a full fellowship to participate in the World Conference, which is the largest annual conference addressing lung health in low and middle-income countries and other limited-resource settings.
The Union Scientific Prize: Dr Kogieleum Naidoo (South Africa) The Union Scientific Prize, acknowledges researchers at any stage of their career for work in lung health that has been published in the last five years. Dr Kogieleum Naidoo received The Union Scientific Prize for research that includes a study of when to initiate antiretroviral drugs during TB treatment that demonstrated a 56% reduction in mortality among patients co-infected with HIV and TB. This highly cited study has been used by the WHO, the United States and South Africa to inform clinical care guidelines for the 1.1 million patients who need simultaneous treatment for TB and HIV. Dr Naidoo is currently the Principal Investigator for a study on TB recurrence in TB-HIV infected patients and head of the Treatment Research Programme for the Centre for the AIDS Programme of Research in South Africa (CAPRISA) in Durban, South Africa.
Congratulations Dr Naidoo and thanks for inspiring a generation of young African scientists 🙂